Find Clinical Trial

Home » Find Clinical Trials » A prospective, controlled, double blind, international study to assess the effects of strontium ranelate vs. placebo on the reduction of periprosthetic bone loss in patients with total hip arthroplasty The “Periprosthetic bone loss” study – The “Periprosthetic bone loss” study

A prospective, controlled, double blind, international study to assess the effects of strontium ranelate vs. placebo on the reduction of periprosthetic bone loss in patients with total hip arthroplasty The “Periprosthetic bone loss” study – The “Periprosthetic bone loss” study

← Back

Study Phase	Phase 3

Therapeutic Area	Rheumatology

Indication	Osteoporosis

Sponsor	Institut de Recherches Internationales Servier (I.R.I.S)

Active substance/ Medical device	STRONTIUM RANELATE, S012911

Active Substance Code	S012911

Protocol Code	CL3-12911-037

EudraCT Code	2010-020215-36

ISRCTN Code	ISRCTN15928978

Documents and links

Results summary	READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.